Post-Doctoral Fellow, Addiction Biology Unit
ContactBiomedical Research Center
251 Bayview Boulevard
Suite 200, Baltimore, MD 21224
B.A. - Psychology & Biology, Boston University
Ph.D. - Psychological Brain Sciences, Boston University
Chloe Jordan received her B.A. in Psychology & Biology with a specialization in Neuroscience, in 2010 and her Ph.D. in Psychological & Brain Sciences, in 2015 from Boston University. Her dissertation focused on understanding the long-term consequences of adolescent ADHD medications on cocaine abuse risk, using a preclinical animal model. She then worked for two years in the Department of Psychiatry at McLean Hospital/Harvard Medical School with Dr. Susan L. Andersen, studying sex differences in neurodevelopmental risk factors and exercise interventions for cocaine use. Chloe joined NIDA-IRP in August 2017 as an IRTA Postdoctoral Fellow in the Addiction Biology Unit, Medicinal Chemistry Section in the Molecular Targets and Medications Discovery Branch. Her current research interests include dissecting cell type-specific neural circuits underlying drug (cannabis, cocaine, and opioid) reward and aversion using transgenic and optogenetic approaches, and neurochemical mechanism-driven medication development for the treatment of substance use disorders.
Addict Biol, 2017, ISSN: 1369-1600 (Electronic); 1355-6215 (Linking).
Dev Cogn Neurosci, 25 , pp. 29–44, 2016, ISSN: 1878-9307 (Electronic); 1878-9293 (Linking).
Psychopharmacology (Berl), 233 (23-24), pp. 3891–3903, 2016, ISSN: 1432-2072 (Electronic); 0033-3158 (Linking).
Behav Brain Res, 297 , pp. 165–179, 2015, ISSN: 1872-7549 (Electronic); 0166-4328 (Linking).
Drug Alcohol Depend, 140 , pp. 25–32, 2014, ISSN: 1879-0046 (Electronic); 0376-8716 (Linking).